• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP

    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP
    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP
    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP storehouse
    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP quality testing
    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP quality testing
    • Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP certificate

    Product Overview:

    Choline glycerophosphate is not only one of the main osmolytes of renal medullary cells, but it is also capable of altering the concentration of osmotic substances inside and outside the cells in parallel. This is beneficial for cerebrovascular health, especially for behavioural and emotional disorders caused by brain decline.

    Choline glycerophosphate has the potential to treat and prevent a wide range of biochemical pathologies. Researchers have found that it alters the structure of phosphate lipid compounds in neuronal membranes and has been found to have a unique ability to relieve tension in the body in relation to factors that trigger neurological tissue decline syndrome.

    Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP Attributes

    Pharmaceutical Choline Alfoscerate Raw Materials Powder CAS 28319-77-9 API Factory Supply

    CAS:28319-77-9

    MF: C8H20NO6P
    Choline glycerophosphate

    MW: 386.66

    EINECS:  248-962-2

    Specification​: 99% min Choline Alfoscerate

    Sample: Choline Alfoscerate Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Pharmaceutical Choline Alfoscerate / Choline Glycerophosphate Raw Materials Powder CAS 28319-77-9 AP Details

    Choline Alfoscerate Powder Usage and Synthesis.

    Choline alfosceraat is op de markt gebracht in Italië, Polen, Griekenland, Chili, Zuid-Korea, Brazilië, Rusland, etc. 

    Choline Glycerofosfaat levert niet alleen hoge gehaltes choline die nodig zijn voor hersen- en zenuwcellen, maar beschermt ook hun celwanden.

    Van choline alfosceraat poeder is in klinisch farmacologisch en klinisch onderzoek aangetoond dat het een gunstig effect heeft op de cognitieve functies en het geheugen bij de ziekte van Alzheimer, die wordt gekenmerkt door een afname van het geheugen en de cognitieve functies, evenals een verscheidenheid aan andere complicaties, zoals mobiliteit en neurologische stoornissen.

    Choline Alfoscerate Powder

    Uses and functions of Choline Alfoscerate Powder.

    Glycerophosphorylcholine (GPC), a water-soluble small molecule normally found in the human body, is a biosynthetic precursor of the important neurotransmitter Acetylcholine.

    The most important role of GPC is that it produces choline as a water-soluble vitamin of the B family, which is important for the brain and the nervous system, and studies have shown that GPC plays an important role in the production of certain hormones and neurotransmitters such as acetylcholine and human growth hormone, thus supporting the function of the brain and the nervous system. 

    Choline Alfoscerate Powder

    Research has shown that GPC is important for the production of certain hormones and neurotransmitters such as acetylcholine and human growth hormone, thus supporting the function of the brain and nervous system.

    Pharmacological Effects of Choline Alfoscerate Powder.

    Choline glycerophosphate is a naturally occurring intermediate in phospholipid metabolism found in cells and throughout the body, structurally consisting of choline, glycerol, and phosphoric acid; it is a major preserved form of choline and is recognised as a source of choline.

    Choline Alfoscerate Powder

    Because it is endogenous, it has very low toxicity and side effects. After absorption, choline glycerophosphate is broken down into choline and glycerophospholipids by the action of enzymes in the body: choline participates in the biosynthesis of acetylcholine, which is a kind of neurotriggering transmitters.

    Production method of Choline Alfoscerate Powder.

    Choline glycerophosphate is not only one of the main osmolytes of renal medullary cells, but it is also capable of altering the concentration of osmotic substances inside and outside the cells in parallel. This is beneficial for cerebrovascular health, especially for behavioural and emotional disorders caused by brain decline.

    Choline Alfoscerate Powder

    Choline glycerophosphate has the potential to treat and prevent a wide range of biochemical pathologies. Researchers have found that it alters the structure of phosphate lipid compounds in neuronal membranes and has been found to have a unique ability to relieve tension in the body in relation to factors that trigger neurological tissue decline syndrome.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,